149 related articles for article (PubMed ID: 3225750)
1. Preformulation study of pelrinone hydrochloride.
Hajdu J; Adams G; Lee HK
J Pharm Sci; 1988 Nov; 77(11):921-5. PubMed ID: 3225750
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical properties of bergenin.
Zhou D; Qin X; Zhang ZR; Huang Y
Pharmazie; 2008 May; 63(5):366-71. PubMed ID: 18557421
[TBL] [Abstract][Full Text] [Related]
3. Preformulation studies on the S-isomer of oxybutynin hydrochloride, an Improved Chemical Entity (ICE).
Luner PE; Kirsch LE; Majuru S; Oh E; Joshi AB; Wurster DE; Redmon MP
Drug Dev Ind Pharm; 2001 Apr; 27(4):321-9. PubMed ID: 11411899
[TBL] [Abstract][Full Text] [Related]
4. Solubility, stability and ionization behaviour of famotidine.
Islam MS; Narurkar MM
J Pharm Pharmacol; 1993 Aug; 45(8):682-6. PubMed ID: 7901363
[TBL] [Abstract][Full Text] [Related]
5. Preformulation characterization and in vivo absorption in beagle dogs of JFD, a novel anti-obesity drug for oral delivery.
Fan Y; Yang M; Wang Y; Li Y; Zhou Y; Chen X; Shan L; Wei J; Gao C
Drug Dev Ind Pharm; 2015 May; 41(5):801-11. PubMed ID: 24694186
[TBL] [Abstract][Full Text] [Related]
6. Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer.
Yamamoto H; Sugano K
Mol Pharm; 2024 Jun; 21(6):2854-2864. PubMed ID: 38718215
[TBL] [Abstract][Full Text] [Related]
7. Preformulation considerations for controlled release dosage forms. Part II. Selected candidate support.
Chrzanowski F
AAPS PharmSciTech; 2008; 9(2):639-45. PubMed ID: 18431656
[TBL] [Abstract][Full Text] [Related]
8. Preformulation studies of a novel camptothecin anticancer agent, CKD-602: physicochemical characterization and hydrolytic equilibrium kinetics.
Kim JH; Lee SK; Lim JL; Shin HJ; Hong CI
Int J Pharm; 2002 Jun; 239(1-2):207-11. PubMed ID: 12052706
[TBL] [Abstract][Full Text] [Related]
9. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
Skrdla PJ; Zhang D
J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
[TBL] [Abstract][Full Text] [Related]
10. Preformulation study of methazolamide for topical ophthalmic delivery: physicochemical properties and degradation kinetics in aqueous solutions.
Jiang S; Wang F; Zhu S; Zhang X; Guo Z; Li R; Xu Q
Int J Pharm; 2013 May; 448(2):390-3. PubMed ID: 23541985
[TBL] [Abstract][Full Text] [Related]
11. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
12. Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability.
Pramar Y; Gupta VD
J Pharm Sci; 1991 Jun; 80(6):551-3. PubMed ID: 1941547
[TBL] [Abstract][Full Text] [Related]
13. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
[TBL] [Abstract][Full Text] [Related]
14. Physico-chemical properties and stabilities of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212).
Shimizu T; Osumi T; Niimi K; Nakagawa K
Arzneimittelforschung; 1984; 34(3A):334-41. PubMed ID: 6540087
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of a new mebendazole salt: mebendazole hydrochloride.
Brusau EV; Camí GE; Narda GE; Cuffini S; Ayala AP; Ellena J
J Pharm Sci; 2008 Jan; 97(1):542-52. PubMed ID: 17854049
[TBL] [Abstract][Full Text] [Related]
16. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
Kang N; Lee J; Choi JN; Mao C; Lee EH
Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
[TBL] [Abstract][Full Text] [Related]
17. Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.
Parasrampuria J; Gupta VD
J Pharm Sci; 1989 Oct; 78(10):855-7. PubMed ID: 2600793
[TBL] [Abstract][Full Text] [Related]
18. Miniaturized approach for excipient selection during the development of oral solid dosage form.
Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
[TBL] [Abstract][Full Text] [Related]
19. Physico-chemical properties and stability of the new hypoxia-selective agent 7-chloro-3-[[N,N-dimethylamino)propyl]amino]-2-quinoxalinecarbonitrile 1,4-di-N-oxide hydrochloride.
Zamalloa E; Aldana I; Bachiller CM; Monge A
Arzneimittelforschung; 1997 Jul; 47(7):873-8. PubMed ID: 9272248
[TBL] [Abstract][Full Text] [Related]
20. Physico-chemical properties and stabilities of the highly potent calcium antagonist benidipine hydrochloride.
Suzuki H; Ono E; Ueno H; Takemoto Y; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1671-6. PubMed ID: 3219139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
